MONECO Advisors’s Biolase, Inc. BIOL Stock Holding History

MONECO Advisors’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12	Closed	-$11K	–	270
2022 Q1	$11K	Hold	12	–	–	﹤0.01%	247
2021 Q4	$11K	Hold	12	–	–	﹤0.01%	246
2021 Q3	$19K	Hold	12	–	–	0.01%	259
2021 Q2	$21K	Sell	12 -2	-14%	-$3.71K	0.01%	223
2021 Q1	$30K	Buy	+14	New	+$34.4K	0.01%	219

Other funds holding BIOL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MONECO Advisors's BIOL Position: Q2 2022 in Review

MONECO Advisors sold out of Biolase, Inc. (BIOL) in Q2 2022, closing a stake of 12 shares — an estimated $11K sold.

MONECO Advisors first reported a position in BIOL in Q1 2021 and held it in 5 quarters. The position peaked at $30K in Q1 2021. 16 funds tracked by Wall St. Rank hold BIOL as of Q2 2022.

MONECO Advisors reported no remaining Biolase, Inc. position as of Q2 2022 after selling out during the quarter.
MONECO Advisors sold 12 Biolase, Inc. shares in Q2 2022, an estimated $11K.
MONECO Advisors first reported a position in Biolase, Inc. in Q1 2021 and held it in 5 quarters.
MONECO Advisors's Biolase, Inc. position peaked at $30K in Q1 2021.
16 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2022.

Based on MONECO Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.